• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜母细胞瘤动脉内化疗中眼动脉超选择性插管的另一种技术:经后交通动脉逆行至眼动脉的入路。

An alternative technique of the superselective catheterization of the ophthalmic artery for intra-arterial chemotherapy of the retinoblastoma: retrograde approach through the posterior communicating artery to the ophthalmic artery.

作者信息

Saglam Muzaffer, Sarici Ahmet, Anagnostakou Vania, Yildiz Bulent, Kocer Naci, Islak Civan, Kizilkilic Osman

机构信息

GATA Haydarpasa Training Hospital, Department of Radiology, Uskudar, Istanbul, 34668, Turkey,

出版信息

Neuroradiology. 2014 Sep;56(9):751-4. doi: 10.1007/s00234-014-1388-1. Epub 2014 Jun 10.

DOI:10.1007/s00234-014-1388-1
PMID:24913287
Abstract

INTRODUCTION

Superselective intra-arterial chemotherapy (IAC) in retinoblastoma has recently become a popular treatment option. In this study, we purposed to investigate the effectiveness of the technique of "retrograde approach through the posterior communicating artery to the ophthalmic artery (OA)" for IAC.

METHODS

A total of 12 unilateral retinoblastomas were treated with IAC in 29 sessions from October 2011 to November 2013. Of the 12 patients, 6 were male and 6 were female, with ages ranging from 12 to 72 months with a median age of 27.6 months. Left-to-right ratio for affected eye was 6/6. In the first 4 patients, we used the ipsilateral internal carotid artery (ICA) to reach the OA of the affected globe (10 sessions). Then, we used the vertebral artery, basilary artery, ipsilateral/contralateral P1 segment of the posterior cerebral artery, and ipsilateral/contralateral posterior communicating artery, respectively, to reach inside the OA at next 15 sessions.

RESULTS

At ipsilateral approach, fluoroscopy total time ranged from 16 to 34 min (mean 21.5 min), and the angle between ophthalmic segment of the ICA and proximal segment of the OA was ranged between 34° and 77° with an average angle of 53.4°. At retrograde approach, fluoroscopy total time ranged from 3 to 12 min (mean 7.5 min), and the angle between ophthalmic segment of the ICA and proximal segment of the OA was ranged between 147° and 178° with an average angle of 148.3°.

CONCLUSION

Retrograde approach makes the IAC procedure easier in retinoblastoma patients and shortens the fluoroscopy time.

摘要

引言

视网膜母细胞瘤的超选择性动脉内化疗(IAC)近来已成为一种流行的治疗选择。在本研究中,我们旨在探究“经后交通动脉逆行至眼动脉(OA)”技术用于IAC的有效性。

方法

2011年10月至2013年11月期间,共对12例单侧视网膜母细胞瘤患者进行了29次IAC治疗。12例患者中,男性6例,女性6例,年龄范围为12至72个月,中位年龄为27.6个月。患眼的左右比例为6/6。在前4例患者中,我们使用同侧颈内动脉(ICA)到达患侧眼球的OA(10次治疗)。然后,在接下来的15次治疗中,我们分别使用椎动脉、基底动脉、大脑后动脉的同侧/对侧P1段以及同侧/对侧后交通动脉到达OA内部。

结果

同侧入路时,透视总时间为16至34分钟(平均21.5分钟),ICA眼段与OA近端段之间的角度为34°至77°,平均角度为53.4°。逆行入路时,透视总时间为3至12分钟(平均7.5分钟),ICA眼段与OA近端段之间的角度为147°至178°,平均角度为148.3°。

结论

逆行入路使视网膜母细胞瘤患者的IAC操作更简便,并缩短了透视时间。

相似文献

1
An alternative technique of the superselective catheterization of the ophthalmic artery for intra-arterial chemotherapy of the retinoblastoma: retrograde approach through the posterior communicating artery to the ophthalmic artery.视网膜母细胞瘤动脉内化疗中眼动脉超选择性插管的另一种技术:经后交通动脉逆行至眼动脉的入路。
Neuroradiology. 2014 Sep;56(9):751-4. doi: 10.1007/s00234-014-1388-1. Epub 2014 Jun 10.
2
Access to the ophthalmic artery by retrograde approach through the posterior communicating artery for intra-arterial chemotherapy of retinoblastoma.经后交通动脉逆行进入眼动脉行视网膜母细胞瘤的动脉内化疗。
Neuroradiology. 2012 Aug;54(8):845-8. doi: 10.1007/s00234-011-0978-4. Epub 2011 Nov 18.
3
The Use of Alternative Routes for the Delivery of Intra-Arterial Chemotherapy for Retinoblastoma.经动脉内化疗治疗视网膜母细胞瘤的不同途径应用。
Neurosurgery. 2020 Oct 15;87(5):956-963. doi: 10.1093/neuros/nyaa142.
4
Effectiveness of alternative routes of intra-arterial chemotherapy administration for retinoblastoma: Potential for response and complications.视网膜母细胞瘤动脉内化疗替代给药途径的有效性:反应及并发症的可能性
Interv Neuroradiol. 2019 Oct;25(5):556-561. doi: 10.1177/1591019919831953. Epub 2019 Mar 31.
5
Risk Factors for Acute Choroidal Ischemia after Intra-arterial Melphalan for Retinoblastoma: The Role of the Catheterization Approach.眼内动脉注射马法兰治疗视网膜母细胞瘤后发生急性脉络膜缺血的危险因素:导管入路的作用。
Ophthalmology. 2021 May;128(5):754-764. doi: 10.1016/j.ophtha.2020.09.021. Epub 2020 Sep 19.
6
Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey.超选择性动脉内化疗在晚期眼内视网膜母细胞瘤初始治疗中的应用:来自土耳其一家机构的首个4年经验
Acta Ophthalmol. 2016 Nov;94(7):e644-e651. doi: 10.1111/aos.13077. Epub 2016 May 23.
7
Incidence and predictors of ophthalmic artery occlusion in intra-arterial chemotherapy for retinoblastoma.眼动脉闭塞在视网膜母细胞瘤的动脉内化疗中的发生率及预测因素。
J Neurointerv Surg. 2021 Jul;13(7):652-656. doi: 10.1136/neurintsurg-2020-016759. Epub 2020 Oct 29.
8
Angiographic investigation of orbital vascular variations in the rabbit and implications for endovascular intra-arterial chemotherapy models.兔眼眶血管变异的血管造影研究及其对经腔内动脉内化疗模型的影响。
J Neurointerv Surg. 2021 Jun;13(6):559-562. doi: 10.1136/neurintsurg-2020-016460. Epub 2020 Sep 11.
9
Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization.经动脉内化疗治疗眼内视网膜母细胞瘤:直接眼动脉插管治疗的替代方法。
AJNR Am J Neuroradiol. 2012 Sep;33(8):1608-14. doi: 10.3174/ajnr.A3019. Epub 2012 Mar 22.
10
The technique of superselective ophthalmic artery chemotherapy for retinoblastoma: The Garrahan Hospital experience.视网膜母细胞瘤超选择性眼动脉化疗技术:加拉汉医院的经验
Interv Neuroradiol. 2018 Feb;24(1):93-99. doi: 10.1177/1591019917738962. Epub 2017 Nov 9.

引用本文的文献

1
Advanced Interventional Treatments in Retinoblastoma Management: A Comprehensive Review.视网膜母细胞瘤管理中的高级介入治疗:综合评价。
Cardiovasc Intervent Radiol. 2024 Apr;47(4):407-415. doi: 10.1007/s00270-024-03692-2. Epub 2024 Mar 20.
2
Contralateral catheterization of the ophthalmic artery to deliver intra-arterial chemotherapy in retinoblastoma.对侧眼动脉插管在视网膜母细胞瘤的动脉内化疗中的应用。
Neuroradiol J. 2021 Aug;34(4):370-372. doi: 10.1177/19714009211024632. Epub 2021 Jun 13.
3
Retrograde Approach through the Posterior Communicating Artery and Anterior Communicating Artery to the Ophthalmic Artery.

本文引用的文献

1
Blue toe syndrome as a complication of intra-arterial chemotherapy for retinoblastoma.蓝趾综合征作为视网膜母细胞瘤动脉内化疗的一种并发症。
JAMA Ophthalmol. 2013 Jun;131(6):801-2. doi: 10.1001/jamaophthalmol.2013.1458.
2
Combined, sequential intravenous and intra-arterial chemotherapy (bridge chemotherapy) for young infants with retinoblastoma.联合序贯静脉和动脉内化疗(桥接化疗)治疗视网膜母细胞瘤的小婴儿。
PLoS One. 2012;7(9):e44322. doi: 10.1371/journal.pone.0044322. Epub 2012 Sep 18.
3
Three-drug intra-arterial chemotherapy using simultaneous carboplatin, topotecan and melphalan for intraocular retinoblastoma: preliminary results.
经后交通动脉和前交通动脉至眼动脉的逆行入路
AJNR Am J Neuroradiol. 2017 Apr;38(4):E28. doi: 10.3174/ajnr.A5081. Epub 2017 Feb 2.
4
Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.视网膜母细胞瘤。五十年的进展。第七十一届爱德华·杰克逊纪念讲座。
Am J Ophthalmol. 2014 Nov;158(5):875-91. doi: 10.1016/j.ajo.2014.07.025. Epub 2014 Jul 24.
三药联合经动脉腔内化疗治疗眼内视网膜母细胞瘤:初步结果。
Br J Ophthalmol. 2012 Oct;96(10):1300-3. doi: 10.1136/bjophthalmol-2012-301925. Epub 2012 Aug 3.
4
Effect of intraarterial chemotherapy on retinoblastoma-induced retinal detachment.眼动脉化疗对视网膜母细胞瘤相关性视网膜脱离的影响。
Retina. 2012 Apr;32(4):799-804. doi: 10.1097/IAE.0b013e31823d8e1e.
5
Access to the ophthalmic artery by retrograde approach through the posterior communicating artery for intra-arterial chemotherapy of retinoblastoma.经后交通动脉逆行进入眼动脉行视网膜母细胞瘤的动脉内化疗。
Neuroradiology. 2012 Aug;54(8):845-8. doi: 10.1007/s00234-011-0978-4. Epub 2011 Nov 18.
6
Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.动脉内化疗治疗视网膜母细胞瘤:四年经验
Arch Ophthalmol. 2011 Jun;129(6):732-7. doi: 10.1001/archophthalmol.2011.5. Epub 2011 Feb 14.
7
Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey.眼内动脉化疗治疗视网膜母细胞瘤:漫漫征程的起点。
Clin Exp Ophthalmol. 2010 Aug;38(6):638-43. doi: 10.1111/j.1442-9071.2010.02297.x. Epub 2010 Mar 25.
8
Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).超选择性眼动脉化疗作为视网膜母细胞瘤(化疗手术)的主要治疗方法。
Ophthalmology. 2010 Aug;117(8):1623-9. doi: 10.1016/j.ophtha.2009.12.030. Epub 2010 Apr 9.
9
Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy.视网膜母细胞瘤的治疗:眼球摘除术、静脉化疗和动脉内化疗的进展。
Curr Opin Ophthalmol. 2010 May;21(3):203-12. doi: 10.1097/ICU.0b013e328338676a.
10
Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy.双侧视网膜母细胞瘤的双侧超选择性眼动脉化疗:串联疗法。
Arch Ophthalmol. 2010 Mar;128(3):370-2. doi: 10.1001/archophthalmol.2010.7.